SGBHD Stock Overview
An investment holding company, provides integrated turnkey solutions for the development of cleanrooms used in laboratories and medical centers in Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Supergenics Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.30 |
| 52 Week High | RM 0.60 |
| 52 Week Low | RM 0.15 |
| Beta | 0.052 |
| 1 Month Change | 100.00% |
| 3 Month Change | n/a |
| 1 Year Change | -40.00% |
| 3 Year Change | 1.69% |
| 5 Year Change | 0% |
| Change since IPO | 7.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| SGBHD | MY Construction | MY Market | |
|---|---|---|---|
| 7D | 100.0% | -0.8% | -1.6% |
| 1Y | -40.0% | 16.5% | -3.7% |
Return vs Industry: SGBHD underperformed the MY Construction industry which returned 16.4% over the past year.
Return vs Market: SGBHD underperformed the MY Market which returned -3.7% over the past year.
Price Volatility
| SGBHD volatility | |
|---|---|
| SGBHD Average Weekly Movement | n/a |
| Construction Industry Average Movement | 5.8% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in MY Market | 10.4% |
| 10% least volatile stocks in MY Market | 2.7% |
Stable Share Price: SGBHD's share price has been volatile over the past 3 months compared to the MY market.
Volatility Over Time: Insufficient data to determine SGBHD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | n/a | Bii Chau Tan | www.supergenic.com.my |
Supergenics Berhad, an investment holding company, provides integrated turnkey solutions for the development of cleanrooms used in laboratories and medical centers in Malaysia. The company is involved in the provision of administrative health care services; and operation of medical laboratories; and development of medical treatment and wellness products. It also offers technology and manufacturing system development services for cell, gene, and tissue therapies; and management services for cleanrooms.
Supergenics Berhad Fundamentals Summary
| SGBHD fundamental statistics | |
|---|---|
| Market cap | RM 34.71m |
| Earnings (TTM) | -RM 7.15m |
| Revenue (TTM) | RM 5.37m |
6.5x
P/S Ratio-4.9x
P/E RatioIs SGBHD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SGBHD income statement (TTM) | |
|---|---|
| Revenue | RM 5.37m |
| Cost of Revenue | RM 3.41m |
| Gross Profit | RM 1.96m |
| Other Expenses | RM 9.11m |
| Earnings | -RM 7.15m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.062 |
| Gross Margin | 36.47% |
| Net Profit Margin | -133.10% |
| Debt/Equity Ratio | 142.4% |
How did SGBHD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/16 04:11 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Supergenics Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.